David Park

David Park_corrected size

Brain and Mind Institute, University of Ottawa, Canada

Dr. Park is an internationally recognized expert in molecular biology focused on understanding the cellular mechanisms involved in Parkinson`s disease (PD) and stroke-related neurodegeneration. His PD research efforts focus on the genetic causes of the disease. He has published extensively on mitochondrial deficits in these contexts and on general mechanisms that contribute to neuronal death, such as oxidative stress and inflammation. His lab, with support from the Krembil Foundation, recently published the first ever clinically-relevant genetic DJ-1 KO mouse model of PD, which displays progressive unilateral to bilateral degeneration accompanied by motor deficits and a heightened immune response. Currently, Dr. Park is a full professor, the uOttawa Brain and Mind Research Institute (uOBMRI) director, the co-founder and co-director of the Parkinson Research Consortium (PRC), an elected Royal Society of Canada Fellow and a member of the Network of Centres of Excellence in Neurodegeneration (COEN). He sits on numerous granting agency panels, serves on various editorial boards and is a Career Heart and Stroke Foundation Scientist. His work has been published in high impact journals such as Nature Cell Biology, Neuron, PNAS, J. Cell Biology, J. Neuroscience and Hum Mol Genetics.


university Agency